In contrast, no significant differences were observed with respect to either PFS or OS in GBM patients, based on ADAM9 expression levels (p = 0.994 and 0.656, log-rank test, PFS and OS, respectively, Figure 3C,D). The gene discussed is ADAM9; the disease is glioblastoma.